Nephrology and Urology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran
10.30491/hpr.2026.247706
Abstract
We wish to highlight a growing concern in urological practice about the increasing rates of sepsis and systemic infections following transrectal ultrasound-guided prostate biopsy (TRUS-PB). Despite being the traditional gold standard for prostate cancer diagnosis, the transrectal method is progressively associated with severe infectious complications, primarily driven by the global rise in antimicrobial resistance.
Sehri,S Y . (2026). Sepsis and Systemic Infection Following Transrectal Prostate Biopsy: A Call for Developing Practices. Hospital Practices and Research, (), 847-847. doi: 10.30491/hpr.2026.247706
MLA
Sehri,S Y . "Sepsis and Systemic Infection Following Transrectal Prostate Biopsy: A Call for Developing Practices", Hospital Practices and Research, , , 2026, 847-847. doi: 10.30491/hpr.2026.247706
HARVARD
Sehri S Y. (2026). 'Sepsis and Systemic Infection Following Transrectal Prostate Biopsy: A Call for Developing Practices', Hospital Practices and Research, (), pp. 847-847. doi: 10.30491/hpr.2026.247706
CHICAGO
S Y Sehri, "Sepsis and Systemic Infection Following Transrectal Prostate Biopsy: A Call for Developing Practices," Hospital Practices and Research, (2026): 847-847, doi: 10.30491/hpr.2026.247706
VANCOUVER
Sehri S Y. Sepsis and Systemic Infection Following Transrectal Prostate Biopsy: A Call for Developing Practices. Hosp Pract Res. 2026;():847-847. doi: 10.30491/hpr.2026.247706
